Clinical Trials Directory

Trials / Completed

CompletedNCT03153436

The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Sohag University · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.

Detailed description

Sperm cryopreservation is considered the most valuable and used way to preserve male reproductive function. Unfortunately, osmotic effects of freezing and thawing during the cryopreservation process negatively affect sperm morphology and motility . Myoinositol is the most biologically important form of inositol in nature. In male reproductive system, myoinositol appears to regulate sperm motility, capacitation and acrosomal reaction. The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.

Conditions

Interventions

TypeNameDescription
BIOLOGICALMyoinositol

Timeline

Start date
2016-08-28
Primary completion
2017-04-26
Completion
2017-04-26
First posted
2017-05-15
Last updated
2017-05-16

Source: ClinicalTrials.gov record NCT03153436. Inclusion in this directory is not an endorsement.